Answer:
C
Explanation:
The investigator should give the subject comprehensive information about the new drug, including its side effects, discuss the pros and cons of both investigational drug and commercially available drug and then allow the subject to decide whether to withdraw from the research to take the new drug.
It is subject's will that he would either take that research treatment or would try the new treatment, but it is the investigator's duty to tell the subject all about the new drug, about its side effects and benefits, its costs and all other benefits or drawbacks.
The answer is A, you need certification
After being bitten by a tick and there's flu-like symptoms with the classic red rash, you're looking at Lyme disease. Medical attention is required at this point.
